Amgen Inc.(AMGN)
Amgen MariTide And Osteoporosis Sales Fuel The Rally (Buy)
(Earnings Call Insights) Amgen outlines $37B–$38.4B 2026 revenue target as Repatha EVENITY and TEZSPIRE drive momentum
Amgen_Q3 Earnings Indicate Strong Emphasis On R&D (Buy)
(Earnings Call Insights) Amgen raises 2025 revenue guidance to $35.8B–$36.6B with 14% volume growth, launches AmgenNow platform
Amgen Non-GAAP EPS of $5.64 beats by $0.63, revenue of $9.6B beats by $630M
Amgen_Imdelltra Could Be The Next Game Changer (Buy)
Amgen Buy The Dip Opportunity (Buy)
